Core Technology

Innovative development of cell therapy using adult stem cells with differentiation potential

   Stem Cell Therapy

EHL Bio is an adult stem cell therapy drug development company that is constantly studying to create a beautiful and healthy future for mankind by making efforts to improve incurable diseases through the innovative development of cell therapy products using adult stem cells with differentiation ability.

  We possess the original technology to independently cultivate adipose stem cells

 Established standardized stem cell production through a fully equipped GMP facility capable of producing advanced stem cells

  Obtained commercial clinical approval for therapeutic agents using adipose-derived stem cells

  PGE2 decomposition inhibitor to enhance stem cell function

   PGE2 Decomposition Inhibitor to Enhance Stem Cell Function

  • Wound Healing

  Low power view showed a large skin defect covered with crust devoid of central reepithelialization

  Higher power view showed a skin defect filled with fibroblastic proliferation and centripetal epidermal ingrowth (asterisks) devoid of central reepithelialization (arrows)

  Lower power view showed a small skin defect devoid of central reepithelialization

  Higher power view showed a skin defect filled with fibroblastic proliferation and centripetal epidermal ingrowth (asterisks) devoid of central reepithelialization (arrows)

  • Increased Stem Cell Proliferation

   Diseases Treatable with Adipose-Stem Cells

Categories: EHLBIOR&D

Translate »